Independent research
We carry out independent research and technological development, ensuring ownership of our advances.
Biophysical Science · Medical Bioengineering
Paso Alto Group
Advanced scienceReal impact
Biomedical research, biophysical science and medical bioengineering focused on oncology applications, infectious disease research and healthcare innovation.
Bioscience
Innovation
Innovation
Rigorous
Research
Research
Real world
Applications
Applications
Ethics &
Integrity
Integrity
More than a biotech company
We do not follow trends.
At Paso Alto Group, we create them.
Paso Alto Group is a research-driven organization focused on biophysical sciences and medical bioengineering, developing innovative technologies for healthcare applications, working on the development of new technologies applicable to healthcare.
Our work focuses on new systems and methods that can be applied in the fight against infectious diseases and in research related to oncology pathologies.
The company carries out independent research and technological development, ensuring that advances achieved in its fields belong exclusively to the company.
Proprietary technology
All our technologies and processes are protected by intellectual property and international treaties.
Global vision
Scientific collaboration and strategic partnerships focused on global impact.
Leadership team
Experience that drives innovation
in
Fidel Valdés
Founder & Chief Executive OfficerPaso Alto Advanced Treatment Center LLC
Telecommunications & Electronics Engineer. Executive leadership, operational management and clinical translation strategy supporting the development and deployment of advanced biophysical technologies.
in
Luis G. Rodríguez
Founder · Director of Research & DevelopmentPaso Alto Group
Physical Sciences & Electronics. Scientific leadership of the group, technology development, molecular interaction modulation research, biomedical engineering programs and innovation strategy.
in
Rafael López
Founder · President & Chief Financial OfficerPaso Alto Group
Economics, Risk Analysis & Intellectual Property. Corporate governance, financial oversight, strategic planning and protection of the group's intellectual and industrial property assets.
Research, development and innovation
Biophysical systems
Development of new technologies based on molecular interaction and physical-electronic approaches.
Infectious disease research
Research into systems and methods applicable to viral inactivation and healthcare innovation.
Oncology applications
Exploration of potential applications in cancer cell lines and oncology-related research.
Institutional Collaborations
Research & Publications
Peer-reviewed publications in Nature Portfolio journals support the scientific development of Paso Alto Group's molecular interaction modulation research.
Publications
natureScientific Reports
Nature Portfolio
Assessment of molecular modulation by multifrequency electromagnetic pulses to preferably eradicate tumorigenic cells
Nature Scientific Reports (2024)
Published scientific evidence supporting the oncology research direction of the technology platform.
DOI: 10.1038/s41598-024-81171-x
Peer reviewedScientific Reports
Read publication ›
natureScientific Reports
Nature Portfolio
Effects of Multifrequency Electromagnetic Pulses on tumor growth in immunocompetent mice
Nature Scientific Reports (2026)
Preclinical oncology-focused publication aligned with the platform's continued translational development.
DOI: 10.1038/s41598-026-49151-5
Peer reviewedScientific Reports
Read publication ›
Certification, safety & regulatory progress
NIVEXOR-M® Platform Validation & Regulatory Pathway
Engineering, safety and compliance activities supporting the transition of the technology toward future human safety and feasibility studies.
Molecular Interaction Modulation Technology
NIVEXOR-M® Platform
Certification, validation and regulatory activities for the NIVEXOR-M® platform.
2025–2026Activities are maintained within the NIVEXOR-M® quality and compliance framework.
A path of continuous development
Molecular Interaction Modulator Prototype I
Laboratory inactivation of viruses
Prototype II development
ASFV modulation research
Animal trial study
Prototype III & oncology applications
Corporate Growth & Oncology In Vivo Validation
Technology optimization for human studies
Certification, validation & regulatory progress
Let’s build the future
of biomedical technology.
Group dedicated to research in Biophysical Sciences and Medical Bioengineering.
info@pasoaltoadvanced.com
2828 Coral Way, Suite 505
Coral Gables, FL 33145, USA